ROR-1 specific chimeric antigen receptors and uses thereof
US12275772B2 · kind B2 · utility
0Cited by
5References
58Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 7, 2021 |
| Grant date | Apr 15, 2025 |
| Priority date | — |
| Expiry date | Feb 5, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2510/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are chimeric antigen receptors (CARs) for cancer therapy, and more particularly, CARs containing a scFv from an anti-ROR-1 monoclonal antibody. Provided are immune effector cells containing such CARs, and methods of treating proliferative disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.